Skip Navigation

Department of Oncologic Pathology

  • Massimo Loda, MD

    Physician-scientist Massimo Loda, MD, Chair of Dana-Farber’s Department of Oncologic Pathology

  • The Department of Oncologic Pathology focuses on innovative discoveries and advances in research and clinical trials in cancer pathology that lead to the development of new care strategies and improved outcomes for patients.

    Research Focus

    The Department of Oncologic Pathology aids investigators throughout the organization in all disease areas as a hub for pathology resources. The Department also focuses on supporting precision medicine and immunotherapy — two of the Institute’s leading research and patient care initiatives — and on developing preclinical models for cancer studies.

    Leadership

    Massimo Loda, MD, is Chair of Dana-Farber’s Department of Oncologic Pathology. He received his MD degree summa cum laude from the University of Milan, Italy. He is a physician-scientist, professor of Pathology at Harvard Medical School, associate member of the Broad Institute, and senior surgical pathologist at Brigham and Women’s Hospital.

    Loda conceived, developed, and directs the state-of-the-art Molecular Pathology Core Laboratory at Dana-Farber. He is a pioneer molecular pathologist and has discovered and explored the mechanism of function of several important cancer biomarkers. Loda’s laboratory has been focused for several years on metabolic alterations in prostate tumorigenesis, with a specific interest in lipid metabolism and its regulation.

  • Support Cancer Research

    To learn more about the many ways you can support Dana-Farber's research initiatives with a philanthropic gift, please contact Allyson Ahern at 617-582-7456 or allyson_ahern@dfci.harvard.edu.

    Join Our Team

    Search job opportunities in our department.

    Contact Us

    Our mailing address is 450 Brookline Avenue, JF830, Boston, MA 02215. To contact us by email: dfci_pathology@dfci.harvard.edu.